Krystal Biotech's total assets for Q1 2025 were $1.07B, an increase of 1.76% from the previous quarter. KRYS total liabilities were $89.74M for the fiscal quarter, a -18.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.